ACADIA

ACADIA is a leading biopharmaceutical company developing treatments for central nervous system disorders, Parkinson“s disease and schizophrenia. ACP-103 and ACP-104 in clinical development.

Keywords: 
ACADIA, ACADIA Pharmaceuticals, biopharmaceutical, biopharmaceutical company, central nervous system disorders, CNS disorders, Parkinson“s disease, schizophrenia, neuropathic pain, glaucoma, ACP-103, ACP-104